Superoxide dismutase: A role in the prevention of chronic lung disease

Biology of the Neonate

Volumn 74, Issue SUPPL. 1, 1998, Pages 29-34

  Davis, Jonathan M ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Antioxidants; Bronchopulmonary dysplasia; Chronic lung disease; Oxygen free radicals; Preterm infants; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; NITRIC OXIDE; OXYGEN RADICAL; SUPEROXIDE DISMUTASE;

CHRONIC LUNG DISEASE; CONFERENCE PAPER; ENZYME LOCALIZATION; GENE THERAPY; LUNG DYSPLASIA; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE;

EID: 0031665413     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047032     Document Type: Conference Paper

References (27)

1. Davis JM, Rosenfeld W: Chronic lung disease; in Avery GB, Fletcher MA, MacDonald MD (eds): Neonatology. Philadelphia, Lippincott 1994, pp 453-477.
2. Soll RF, McQueen MC: Respiratory distress syndrome; in Sinclair JC, Bracken MB (eds): Effective Care of the Newborn Infant. New York, Oxford University Press, 1992, pp 325-358.
3. Bregman J, Farrell EE: Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. Clin Perinatol 1992,19:673-694.
4. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD: Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994;36:244-252.
5. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L: Elastase and alpha I-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983;72: 656-666.
6. 2 rich environment: The antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984;18:240-244.
7. Frank L: Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991; 11:463-494.
8. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A: Prophylactic effects of recombinant human Superoxide dismutase in neonatal lung injury. J Appl Physiol 1993;74:2234-2241.
9. Turrens JF, Crapo JD, Freeman BA; Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73:87-95.
10. Padmanabhan RV, Gudapaty R, Liener IE, Schwartz BA, Hoidal JR; Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated Superoxide dismutase or catalase. Am Rev Respir Dis 1985;132:164-167.
11. Walther FJ, Gedding CE, Kuipers IM, Willebrand D, Bevers EM, Abuchowski A, Viau AT: Prevention of oxygen toxicity with Superoxide dismutase and catalase in premature lambs. Free Radic Biol Med 1986;2: 289-293.
12. Freeman BA, Young SL, Crapo JD: Liposome-mediated augmentation of Superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 1983;258:12534-12542.
13. Rosenfeld WN, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A: Prevention of bronchopulmonary dysplasia by administration of bovine Superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984;105:781-785.
14. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kassem N: Safety and pharmacokinetics of recombinant human Superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996;97:811-817.
15. Davis JM, Rosenfeld WN, Richter SE, Parad R, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Horowitz S: Safety and pharmacokinetics of multiple doses of recombinant human CuZn Superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24-30.
16. Matalon S, Holm BA, Baker RR, Whitefield MK, Freeman BA: Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990;1035: 121-127.
17. Carlsson LM, Jonsson J, Edlun T, Marklund SL: Mice lacking extracellular Superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995;92:6264-6268.
18. Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, Whitsett JA: Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992;267:23937-23941.
19. Sahgal N, Davis JM, Robbing CG, Horowitz S, Langenback EG, Perry RH, Colflesh D, Tierney J, Simon SR: Localization and activity of recombinant human CuZn Superoxide dismutase after intratracheal administration. Am J Physiol 1996;71: L230-L235.
20. Das S, Horowitz S, Robbins CG, El-Sabban ME, Sahgal N, Davis JM: Intracellular uptake of recombinant superoxide dismutase after intratracheal administration. Am J Physiol 1998;274, in press.
21. Hastings RM, Wright JR, Albertine KH, Ciriales R, Matthay MA: Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G, and SP-A in rabbits. Am J Physiol 1994;266:L544-L552.
22. Hastings RH, Folkesson HG, Petersen V, Ciriales R, Matthay MA: Cellular uptake of albumin from lungs of anesthetized rabbits. Am J Physiol 1995;269:L453-L462.
23. Biswas S, Richter SE, Rosenfeld WN, Gewolb IH, Parad R, Couser RJ, Baumgart S, Kassem N, Edwards L, Davis JM: Long term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn Superoxide dismutase (abstract). Pediatr Res 1998;43:208.
24. Robbins CG, Davis JM, Merritt TA, Amirkanian JD, Sahgal N, Morin FC, Horowitz S: Combined effects of nitric oxide and hpyeroxia on surfactant function and pulmonary inflammation. Am J Physiol 1995; L545-L550.
25. Robbins CG, Horowitz S, Merritt TA, Kheiter A, Tierney J, Narula P, Davis JM: Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol 1997; 272:L903-L907.
26. Albert G, Davis JM, Robbins CG, Horowitz S, Steinhorn RH: Superoxide dismutase as an adjunctive therapy for inhaled nitric oxide (abstract). Pediatr Res 1998;43:272.
27. Keszler M, Modanlou HD, Brudno S, Clark FI, Cohen RS, Ryan RM, Kaneta MK, Davis JM. Multi-center controlled clinical trial of high frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 1997;100:593-599.